In 2494 adults having elective colorectal surgery (2457 analysed), target-controlled cefoxitin infusion vs standard dosing did not reduce 30-day surgical site infection (5.6% vs 5.6%; RR 1.01) but lowered intraoperative dose (median 1.38 vs 2.00 g).
RCTn = 2,494
Lee et al. Target-controlled infusion vs. standard dosing of cefoxitin for surgical prophylaxis in colorectal surgery: a randomized clinical trial